A Study of TAVO412 in Patients with Cancer (TAVO412)

NCT06761651 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
50
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tavotek Biotherapeutics